hotspot -WSS

hotspot

author：fashion 2025-10-01 11:45:47 - browse：513

The Novartis booth at ESMO in Madrid. — The Novartis booth at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Results presented Monday could expand the use of a Novartis therapy for metastatic prostate cancer, moving it from a treatment used after chemotherapy to one with demonstrated benefits beforehand as well.

The Phase 3 data, highlighted in a prime session here at the annual meeting of the European Society for Medical Oncology, also amount to another win for cancer therapies designed to deliver radiation directly to tumor cells. It’s a field that Novartis has poured investments into, and that is attracting interest from other pharma companies.

The trial, called PSMAfore, enrolled patients with a type of metastatic prostate cancer whose disease had started to progress after taking a drug known as an androgen receptor pathway inhibitor, or ARPI. Patients were randomized to either receive a different ARPI or Novartis’ therapy, Pluvicto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Illinois Supreme Court finds assault weapons ban constitutional

entertainment

leisure time

WSS

Schizophrenia gene found to be linked to cells' energy dysfunction

Senators push IRS to launch nonprofit hospital probe

Aspartame and sugar

In key trial, Verve's treatment lowers cholesterol levels in patients

BMS, looking to build heart drug business, turns to AI for diagnosis

YouTube cracks down on misinformation on cancer treatment

focus

hotspot

leisure time

Virginia high school admissions case could be legal follow

Astellas still sees hope in its gene therapy after four deaths

In age of alternative facts, a scholarly course on calling out crap

Aspartame and sugar

Moonlake's readout produced a cash windfall. Risks remain

Childhood cancer progress stalls for Black, Hispanic kids: Report

Activists slam private health insurers over coverage restrictions

Megan Rapinoe shares emotional post following US Women's World Cup exit

Malaria cases in Florida and Texas: Here’s what you need to know

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

leisure time

Congress must reauthorize a committee to support older Americans

Ransomware attacks on hospitals: Study outlines patient impact

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

What to know about the judge who will handle the Trump case

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Biogen’s boardroom scandal saddles CEO with first crisis

entertainment

leisure time

leisure time

explore